Patents
From foundational patents to delivery technology, we have pioneered the development of mRNA medicine since our founding. Along the way, we have accumulated a broad collection of patents, with several hundred additional pending patent applications.
Intellectual Property
The following are protected by patents in the United States and in foreign jurisdictions for Moderna Inc.
Spikevax™ (mRNA-1273 COVID-19 VACCINE)